Indaptus Therapeutics INDP Stock Is It a Good Entry Point Indaptus Therapeutics misses EPS views no revenue LPTH LightPath Technologies gains 10 percent in daily trading even as Q1 2026 earnings sharply miss analyst expectations DexCom Inc DXCM High Free Cash Flow Profile Positions It as a Top Weekly Pick Amid Peers Operational Headwinds